GSK-1268992

Details

Stereochemistry	ACHIRAL
Molecular Formula	C21H23N7O3S
Molecular Weight	453.517
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN(C1=CC2=NN(C)C(CO)=C2C=C1)C3=CC=NC(NC4=CC=C(C)C(=C4)S(N)(=O)=O)=N3

InChI

InChIKey=KRXYEFGZHAJXHW-UHFFFAOYSA-N

InChI=1S/C21H23N7O3S/c1-13-4-5-14(10-19(13)32(22,30)31)24-21-23-9-8-20(25-21)27(2)15-6-7-16-17(11-15)26-28(3)18(16)12-29/h4-11,29H,12H2,1-3H3,(H2,22,30,31)(H,23,24,25)

HIDE SMILES / InChI

Molecular Formula	C21H23N7O3S
Molecular Weight	453.517
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 09:13:03 UTC 2023` Edited by `admin` on `Sat Dec 16 09:13:03 UTC 2023`
Record UNII	SX3LHF7K66
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

GSK-1268992

Common Name

English

PAZOPANIB METABOLITE M24

Common Name

English

GSK1268992

Code

English

5-((4-((3-(HYDROXYMETHYL)-2-METHYL-INDAZOL-6-YL)-METHYL-AMINO)PYRIMIDIN-2-YL)AMINO)-2-METHYL-BENZENESULFONAMIDE

Systematic Name

English

Code System Code Type Description

PUBCHEM

72942037

Created by admin on Sat Dec 16 09:13:03 UTC 2023 , Edited by admin on Sat Dec 16 09:13:03 UTC 2023

PRIMARY

CAS

1414375-49-7

Created by admin on Sat Dec 16 09:13:03 UTC 2023 , Edited by admin on Sat Dec 16 09:13:03 UTC 2023

PRIMARY

FDA UNII

SX3LHF7K66

Created by admin on Sat Dec 16 09:13:03 UTC 2023 , Edited by admin on Sat Dec 16 09:13:03 UTC 2023

PRIMARY

Related Record Type Details


					7RN5DR86CK

PAZOPANIB

PARENT -> METABOLITE INACTIVE

Comments:

Four pazopanib metabolites (GSK1268992, GSK1268997, GSK1071306, and GW700201) have been identified. Only one of these metabolites (GSK1268997) has been shown to inhibit the proliferation of VEGF-stimulated human umbilical vein endothelial cells with potency similar to pazopanib. The other metabolites show at least 10- to 20-fold less activity than the parent compound in the same cellular assay.